Proton Therapy Safe and Effective Treatment for Children with Tumors Near the Brainstem
|
By MedImaging International staff writers Posted on 24 Oct 2013 |
Proton therapy can be used to safely treat pediatric sarcomas and brain tumors adjacent to the brainstem, according to a new study.
The study’s findings were presented October 2013 at the American Society for Radiation Oncology’s 55th annual meeting, held in Atlanta (GA, USA), by lead researcher Daniel J. Indelicato, MD, associate professor in the University of Florida (UF; Gainesville, USA) department of radiation oncology, described the findings of 313 children who received a high radiation dose to the area around the brainstem, and is the largest study of this type ever presented. More than 90% of these children treated at UF Proton Therapy Institute (Jacksonville, USA) since 2006 survived beyond two years and the rate of serious side effects involving the brainstem was 2%.
“This study provides important evidence that proton therapy may be safely delivered to our most vulnerable patients with challenging tumors,” said Dr. Indelicato. “Whenever a child experiences a side effect from radiation that impacts the brainstem, it is a very serious and potentially life-threatening event. Across our entire discipline, regardless of the treatment modality, pediatric radiation oncologists need more information to identify patients at risk. This study contributes valuable radiation dose parameters to help guide the design of safe radiation treatment plans.”
Most of the children treated at the UF Proton Therapy Institute have tumors in this critical location near the base of the skull and spinal cord. Proton therapy provides an advantage in these children, because the developing brain is exposed to less radiation. Moreover, proton therapy may limit the dose to a child’s hearing, hormone, and vision centers neighboring the tumor.
Related Links:
University of Florida
University of Florida Proton Therapy Institute
The study’s findings were presented October 2013 at the American Society for Radiation Oncology’s 55th annual meeting, held in Atlanta (GA, USA), by lead researcher Daniel J. Indelicato, MD, associate professor in the University of Florida (UF; Gainesville, USA) department of radiation oncology, described the findings of 313 children who received a high radiation dose to the area around the brainstem, and is the largest study of this type ever presented. More than 90% of these children treated at UF Proton Therapy Institute (Jacksonville, USA) since 2006 survived beyond two years and the rate of serious side effects involving the brainstem was 2%.
“This study provides important evidence that proton therapy may be safely delivered to our most vulnerable patients with challenging tumors,” said Dr. Indelicato. “Whenever a child experiences a side effect from radiation that impacts the brainstem, it is a very serious and potentially life-threatening event. Across our entire discipline, regardless of the treatment modality, pediatric radiation oncologists need more information to identify patients at risk. This study contributes valuable radiation dose parameters to help guide the design of safe radiation treatment plans.”
Most of the children treated at the UF Proton Therapy Institute have tumors in this critical location near the base of the skull and spinal cord. Proton therapy provides an advantage in these children, because the developing brain is exposed to less radiation. Moreover, proton therapy may limit the dose to a child’s hearing, hormone, and vision centers neighboring the tumor.
Related Links:
University of Florida
University of Florida Proton Therapy Institute
Latest Nuclear Medicine News
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







